HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,790 | +10.0% | 44,021 | 0.0% | 0.02% | +6.7% |
| Q4 2023 | $1,627 | -7.7% | 44,021 | -4.6% | 0.02% | -16.7% |
| Q3 2023 | $1,762 | +100.5% | 46,121 | +89.2% | 0.02% | +125.0% |
| Q2 2023 | $879 | +4.1% | 24,374 | +10.3% | 0.01% | 0.0% |
| Q1 2023 | $844 | -48.3% | 22,104 | -23.0% | 0.01% | -52.9% |
| Q4 2022 | $1,633 | -99.8% | 28,690 | +10.0% | 0.02% | +41.7% |
| Q3 2022 | $1,031,000 | +53.0% | 26,090 | +54.4% | 0.01% | +71.4% |
| Q1 2022 | $674,000 | -8.4% | 16,900 | -7.7% | 0.01% | 0.0% |
| Q4 2021 | $736,000 | -1.1% | 18,300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $744,000 | -10.5% | 18,300 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $831,000 | +8.9% | 18,300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $763,000 | -11.6% | 18,300 | -9.4% | 0.01% | -11.1% |
| Q4 2020 | $863,000 | – | 20,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |